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Abstract: Heterochrony is an enabling concept in evolution theory that metaphorically captures
the mechanism of biologic change due to mechanisms of growth and development. The
spatio-temporal patterns of morphogenesis are determined by cell-to-cell signaling mediated by
specific soluble growth factors and their cognate receptors on nearby cells of different germline
origins. Subsequently, down-stream production of second messengers generates patterns of form
and function. Environmental upheavals such as Romer’s hypothesized drying up of bodies of
water globally caused the vertebrate water-land transition. That transition caused physiologic stress,
modifying cell-cell signaling to generate terrestrial adaptations of the skeleton, lung, skin, kidney
and brain. These tissue-specific remodeling events occurred as a result of the duplication of the
Parathyroid Hormone-related Protein Receptor (PTHrPR) gene, expressed in mesodermal fibroblasts
in close proximity to ubiquitously expressed endodermal PTHrP, amplifying this signaling pathway.
Examples of how and why PTHrPR amplification affected the ontogeny, phylogeny, physiology
and pathophysiology of the lung are used to substantiate and further our understanding through
insights to the heterochronic mechanisms of evolution, such as the fish swim bladder evolving into the
vertebrate lung, interrelated by such functional homologies as surfactant and mechanotransduction.
Instead of the conventional description of this phenomenon, lung evolution can now be understood
as adaptive changes in the cellular-molecular signaling mechanisms underlying its ontogeny
and phylogeny.
Keywords: evolution; heterochrony; cell-cell signaling; synchronic; diachronic; growth factor; growth
factor receptor
1. Introduction
Heterochrony is an enabling concept in evolution theory because it captures the image of
dynamic biologic change diachronically across space and time. The term heterochrony (see
Table 1 below) was first used by Haeckel in his explanation of the Biogenetic Law [1]. De Beer
subsequently used Heterochrony to denote differences in the ontogenies of related taxa [2]. The
latter comparative definition is the one in principal use [3]. More recent interest in the question of
Heterchrony has arisen because of the integration of developmental biology into evolution theory, or
EvoDevo [4]. But this initiative has failed to incorporate the highly mechanistic nature of contemporary
Developmental Biology [5] beginning in the late 1970s with the discovery of soluble growth factors
and their complementary receptors residing on neighboring cell-types, determining the patterns of
morphogenesis [6]. The associations of growth factors with the process of evolution are sometimes
described [7], but the significance of the growth factor receptors, down-stream signals and subsequent
effects on morphogenesis are never specifically addressed—yet this is a microcosm of what evolution
constitutes, if only we would perceive it appropriately [8–10]. The only reasonable explanation for
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such gross oversights is that Cell Biology itself has been overarched by the evolutionists, largely due to
an incident of history [11]. Haeckel and Spemann were unable to provide scientific evidence for their
theories of the Biogenetic Law, and for the “Organizer”, respectively, so the evolutionists turned to the
geneticists to advance their agenda, rejecting the embryologists in the process. As a result, the nominal
mechanism of evolution is constituted by genetic mutation and natural selection [12]. If this were
indeed the case, then there would be no need to delineate or utilize the principles of cellular-molecular
morphogenesis, yet therein lie the fundamental principles of form and function [13]. The following is in
service to functionally integrating our contemporary knowledge of the cellular-molecular mechanisms
of development with the role of heterochrony in evolutionary biology.
Table 1. Background and significance for the reinterpretation of heterochrony.
‚ The concept of heterochrony was first introduced by Ernst Haeckel in 1875 as the mechanistic basis for his
Biogenetic Law.
‚ Heterochrony is due to a change in function or form during development.
‚ Kolman (1885) used the term paedomorphosis to describe heterochrony as process for retaining
juvenile properties.
‚ De Beer (1930) used the term neoteny as a subcategory of heterochrony to describe the retention of earlier
developmental properties.
‚ Peramorphosis is used to describe delayed maturation and extended periods of growth.
‚ In his book “Ontogeny and Phylogeny”, Stephen J. Gould described the significance and importance of
heterochrony as the mechanism of evolution. However, he never provided a specific mechanism for how
and why such changes occur, obviating the possibility of scientifically testing its hypothesized role
in evolution.
‚ Since the late 1970s, the determination of growth and differentiation by soluble growth factor-mediated
cell-cell signaling has been acknowledged to be the mechanism of development.
‚ Despite this, the advent of Evolutionary Developmental Biology, or EvoDevo has not assimilated growth
factor signaling into its analyses.
‚ The current article demonstrates the value added in understanding heterochrony as a sequence of cell-cell
interactions that can be modified by environmental factors to understand how and why evolution has
occurred. The power of this approach is in its ability to understand the processes of development,
physiology, homeostasis and pathology as one continuous, scale free evolutionary mechanism for the
first time.
‚ This explanation of heterochrony offers a change in the language of evolutionary biology, representing
what Kuhn [14] referred to as a paradigm shift in his “The Structure of Scientific Revolutions”.
2. Normal Embryologic Development, or “Monochrony”, in Contrast to Heterochrony
The spatio-temporal patterns of vertebrate embryogenesis are determined by the elaboration of
cell-specific growth factors signaling to their cell surface G-Protein Coupled Receptors are neighboring
cells of differing germline origins to form patterns of growth and differentiation, from the zygote [15]
to the offspring [16]. This is an iterative process by which the zygote divides, giving rise to the animal
and vegetal poles, the blastula, gastrula, and so on [17] during embryogenesis, followed by fetal
growth and differentiation [18] to generate the offspring. All of these processes are mediated by
growth factor-receptor signaling mechanisms that form the tissues and organs of the body. If the
environmental conditions remain unchanged, this process would simply be recapitulated from one
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life cycle to the next. But the environment is in perpetual flux [19]—climate, topography, seasons,
food abundance, competition with other organisms—so organisms must be able to adapt in order
to survive using the mechanism we refer to as evolution [20]. This is particularly apparent when
environmental conditions are physiologically stressful, since the adaptive changes are both discernable
and measurable [21]. Classic examples are the consequences of the five mass extinctions [22], and the
transition of plants and animals from water to land [23], brought about by carbon dioxide causing
an atmospheric Green House Effect that dried up water sources globally [24]. During that period
there were several genetic adaptations that profoundly affected vertebrate physiology, allowing for
successful adaptation to terrestrial life [10]. By focusing on those events both ontogenetically and
phylogenetically [10], we can envision how heterochrony facilitated vertebrate evolution.
The terrestrial forms of the vertebrate lung, kidney, bone, skin and brain all evolved during the
water-land transition in adaptation to terrestrial life. The epitome of the mechanisms underlying
these phenotypic changes is the duplication of the Parathyroid Hormone-related Protein Receptor
(PTHrPR) [25], expressed in all of these organs by the mesoderm [26] in close proximity to ubiquitous
epithelial PTHrP production. The duplication of the PTHrPR gene amplified signal transduction for
PTHrP signaling from the endodermal epithelium to the mesodermal fibroblast [27]. In the case of the
lung, it facilitated the formation of alveoli [28]; in the kidney, PTHrP signaling amplification generated
glomeruli [29]; in bone, increased PTHrP amplification allowed for the five documented phenotypic
changes in the skeleton that compensated for the increased effect of gravity on the skeleton relative to
buoyancy in water [30]; in the skin, PTHrP fostered barrier formation by skin cells for prevention of
water and electrolyte loss [31]; the brain is thought to have evolved from the skin [32], and it has a
number of molecular traits that are derivative of the latter at the molecular level [9] that would have
facilitated its evolution for land adaptation.
3. Lung Evolution as Ontogeny and Phylogeny
In hindsight, it is obvious that land vertebrates had to evolve lungs in order to adapt to air
breathing, yet phylogenetically the fish organ of gas exchange—the gill—is an analog of the lung,
not the functionally ancestral homolog—counterintuitively, the fish swim bladder, which facilitates
buoyancy, is actually the functional homolog of the lung [33]. This example epitomizes the value
of a cellular-molecular ontogenetic-phylogenetic approach to evolution. The swim bladder is an
adaptation to gravity that utilizes atmospheric gas to inflate or deflate the bladder, aided by the
secretion of cholesterol into the air space by the gas gland epithelium. The swim bladder expresses
both Cholesterol, the most primitive lung lipid component of surfactant [34], and Surfactant Protein
A [35], a host defense peptide that originated phylogenetically from the gut.
The lung has adapted to atmospheric oxygen phylogenetically and ontogenetically by reducing
the surface area of the gas exchange unit, increasing the ratio of the gas-exchange surface area to
the blood volume for increased oxygenation. Concomitant ontogenetic and phylogenetic increases
in the biological activity of lung surfactant secreted into the alveolar space prevented the alveolar
collapse that would otherwise have been caused by the increase in surface tension resulting from the
decreased surface area (surface tension being inversely related to surface area by the Law of Laplace).
The stretch-regulated mechanism of alveolar surfactant production [10] is functionally homologous
with the swim bladder, both of which are gravity-sensing mechanisms [30]. By focusing on the
developmental/homeostatic cell-cell interactions that have evolved from the gas-exchange unit of fish
(swim bladder) to that of land vertebrates to form the alveoli [36], one can see how they were selected
for the thinning of the alveolar wall and the anti-atelectatic function of the surfactant system [37].
4. The Lipofibroblast as a “Rosetta Stone” for Lung Evolution
The alveolar lipofibroblast (LIF) is a molecular Rosetta Stone [38], “translating” the developmental
changes across vertebrate species into the evolution of the lung. The physiologic relevance of the LIF to
alveolar growth, differentiation, homeostasis and repair has revealed such evolutionary homologies as
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(1) the peroxisome [39], which is thought to have evolved in response to the otherwise pathologic effects
of Endoplasmic Reticulum stress in unicellular organisms; (2) Neutral Lipid Trafficking (Figure 1) [40],
encompassing facilitated lipid uptake in defense against hyperoxia [41] mediated by Adipocyte
Differentiation Related Protein (ADRP) storage [42], and release under the control of Prostaglandin
E2 [43], referring all the way back to the biosynthesis and insertion of cholesterol into the eukaryotic cell
membrane [8]; and (3) the secretion of the fat cell hormone leptin [44] to regulate surfactant production
by the Alveolar Type II Cell (ATII), coming full circle from the antioxidant property of the LIF [41]. For
orientation of these cellular-molecular evolutionary properties to the lung, the pathways for ontogeny,
phylogeny and evolution of the LIF-ATII interactions are depicted in Figure 2.
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Figure 1. Active recruitment of neutral lipid from lipofibroblasts by alveolar Type II cells. Neutral
lipids stored in lipofibroblasts are actively “trafficked” to alveolar Type II cells by means of Adipocyte
Differentiation Related Protein (ADRP), regulated by Parathyroid Hormone-related Protein (PTHrP)
produced by Type II cells. The Type II cells secrete Prostaglandin E2, stimulating the secr tion of the
neutral lipids, and the uptake of the neutral lipid by the Type II cells is regulated by leptin produced
by the lipofibroblasts. Each of these steps is coordinately stretch-regulated to increase surfactant
phospholipid synthesis by the Type II cell. The net result is surfactant phospholipid production
integrated with the distension of the alveolar wall during breathing.
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Figure 2. Pathways for the d velopmental phyletic evolution o li ofibr blast-Type II cell
interactions. Extrinsic selection pressures are shown in italics; intrinsic selection pressures are
shown in bold. (1) AMPs = Antimicrobial Peptides; (2) VDR = Vitamin D Receptor; (3) Type IV
col = Type IV collagen ; (4) GR = Glucocorticoid Receptor; (5) 11βHSD = 11beta Hydroxysteroid
Dehydrogenase; (6) βAR = beta Adrenergic Recept ; (7) ADR Adipocyte Differentiation Related
Protein; (8) Le tin = Leptin; (9) Leptin R = Leptin Receptor; (10) PTHrP = Parathy oid Hormone-related
Protein; (11) SP-B = Surfactant Protein-B. These changes in genetic expression were sequentially brought
about by such environmental factors as salinity, water-land transition and fluctuations in atmospheric
oxygen tension over the last 500 million years.
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LIFs in the alveolar wall of the rat lung were first described by Hitchcock et al. [45], and extensively
documented in rodent [46–48] and more recently in human lung [49]. However, their functional
relevance to the alveolus was not determined for two more decades, though their cytoprotective
nature was suggested earlier by the comparative lung physiologic studies of Frank et al. [50], who
showed the association between the LIFs and their putative role in antioxidant protection. These
physiologic studies were paralleled by biochemical studies of triglyceride metabolism conducted by
Mostello et al. [51].
The breakthrough in understanding the functional nature of these cells in lung alveolar physiology
came with the co-culture of LIFs containing radiolabeled triglyceride and naive ATIIs, resulting in
rapid passage of the tagged triglyceride from the LIF to the ATII, and their subsequent robust, enriched
incorporation into surfactant phospholipid [52], termed Neutral Lipid Trafficking. Experimentally, it
was observed that LIFs could readily take up triglyceride and store it in a stable form; furthermore, this
process was under hormonal control by glucocorticoids, pointing to its regulated nature. Moreover,
the presence of neutral lipid droplets in the LIFs protected them against oxidant injury [41], providing
a function for these cells for the first time. It was subsequently determined that the uptake, storage
and transit of the neutral lipids was actively mediated by ADRP, one of the proteins that mediate the
trafficking and storage of neutral lipids throughout the body [53].
As mentioned above, during the course of these studies, it was empirically discovered that ATIIs
could not absorb triglycerides (TGs) [52], whereas LIFs could not release them. That led to the discovery
that Prostaglandin E2 (PGE2), secreted by ATIIs [43], specifically causes PGE2 receptor-mediated release
of TGs by LIFs, and leptin produced by the LIFs facilitates the uptake of TGs by binding to its cell
surface receptors on ATIIs [44].
The climax of these coordinated cell-cell interactions mediating and facilitating the production of
lung surfactant was the discovery that Neutral Lipid Trafficking is stretch-regulated, providing key
insights into both the cellular-molecular basis for the mechanism of alveolar ventilation-perfusion
matching [54], and to the evolutionary history of the lung [54]. Initially, it was discovered that
PTHrP is necessary for the formation of alveoli during lung morphogenesis [27], and that PTHrP
secreted by the ATIIs stimulates LIF development, including TG uptake [55] and leptin secretion [44],
providing evidence for the earliest epithelial signal to the mesenchyme during the course of the cell-cell
interactions that mediate alveolar development. That, combined with the observation that PTHrP
mRNA expression by ATIIs is stretch-regulated [56] led to the broader physiologic insight that the
PTHrP Receptor (PTHrPR), leptin and the leptin receptor are all stretch-regulated signals, coordinating
the physical distension of the alveolar wall with the “on-demand” up-regulation of surfactant
production [40], promoting lung development in utero [57], and preventing alveolar atelectasis during
air breathing [54]. The elucidation of this cellular-molecular mechanism for ventilation-perfusion
matching is the first such evidence for the cellular-molecular basis for a physiologic property ever to
be determined.
The ancestral relationship between the effect of stretch on PTHrP expression and microgravity was
subsequently shown empirically. ATIIs were subjected to 0 ˆ g conditions using a Rotating Wall Vessel
Bioreactor [30]. The amount of PTHrP mRNA decreased over the first 8–12 h of microgravitational
exposure, reaching a new stable baseline; when the cells were returned to unit gravity, the amount
of PTHrP mRNA returned to its pre-microgravity exposure level. The deep significance of this
relationship between alveolar regulation, mechanotransduction and lung development was revealed
by study of the effect of microgravity on yeast [58]. Exposure to 0 ˆ g caused loss of polarity and
budding. The former is a reflection of the inability to mediate calcium flux [59], and the latter reflects
the inability to reproduce [60]. These ancient physiologic properties refer all the way back to the
unicellular state, when cholesterol facilitated eukaryotic evolution from prokaryotes, promoting
metabolism, respiration and locomotion, the basic characteristics of vertebrate evolution [61].
These insights led to the realization that the endodermal and mesodermal components of the
alveolar wall evolved over evolutionary time to generate their structural-functional properties through
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cell-cell interactions [8,36,62]. In support of that process, the PTHrPR duplicated during the vertebrate
water-land transition some 300 mya (Million years ago) [25], amplifying the PTHrP signaling pathway
in the lung, skin and bone. The causal nature of this interrelationship is evidenced by the deletion
of PTHrP in developing mice, causing failure of lung, skin and bone development [27]. PTHrP is
also expressed in the developing swim bladder along with many other genes expressed in lung [33],
establishing the functional homology between these organs. Moreover, the gas gland epithelial cells
that line the swim bladder secrete cholesterol, the most primitive lung surfactant, preventing the
walls of the bladder from sticking to one another. That functional homology relates ancestrally all the
way back to the advent of cholesterol in the cell membranes of evolving unicellular eukaryotes from
prokaryotes, thinning the phospholipid bilayer, facilitating oxygenation, metabolism and locomotion,
the fundamental properties of vertebrate physiologic evolution [61]. Cholesterol was subsequently
coopted for the formation of lipid rafts, the structural site for cell-surface receptors, and much later
were the substrate for steroid hormones and vitamin D, key elements of the endocrine system.
5. Physical Stress and Heterochrony—The Role of Gravity
Gravitational force is the oldest, constant, unidirectional force on Earth. As such, it affects biologic
systems through mechanotransduction to affect cellular physiology. The fundamental nature of this
effector is reflected by experiments in which yeast were exposed to microgravity, showing phenotypic
effects on polarity and budding [58]. The former effect is a reflection of the role of gravity in calcium
flux [59], the latter reflecting the effect of gravity on reproduction [60]. Experiments in our laboratory
have similarly shown effects of microgravity on PTHrP expression in lung and bone cells in vitro [29],
which were corroborated by assaying for PTHrP mRNA in the bones of rats flown in deep space for
two weeks on NASA STS-58 [30]. The mRNA levels were significantly lower in the weight-bearing
bones (tibia, femur) than in the non-weight bearing skull bones [30], consistent with the theory of
mechanical effects on bone remodeling.
Affecting such fundamental adaptive mechanotransductive mechanisms has produced
heterochronic changes over the history of organisms.
6. Physiologic Stress—The Role of Hypoxia
Oxygen has profoundly affected the evolution of terrestrial organisms, fueling their metabolism,
causing increased growth [62] and differentiation [8]. This effect is most apparent over the course
of the last 500 million years, during the Phanerozoic eon, oxygen rising and falling between 15%
and 35% [63]. The increases have driven the growth of large insects and animals [64], whereas
the subsequent decreases have profoundly affected visceral evolution since hypoxia is the most
potent physiologic stressor. The residual of those insults is seen in the concerted evolution of the
neuroendocrine [65], endocrine [66] and respiratory systems [8] of land vertebrates, hypothetically
generating homeothermy/endothermy [10].
As added evidence for the interrelationship between physiologic stress and the co-evolution
of the neuroendocrine and respiratory systems, lung surfactant has evolved to optimize surface
tension reducing activity during the transition from poikilotherms to endotherms [66]. Initially, the
stress of periodic hypoxia during land vertebrate evolution stimulated the hypothalamic-pituitary
adrenal axis, increasing catecholamine secretion from the adrenal medulla [67]. Catecholamines
stimulate surfactant secretion by the alveoli, making the alveoli more distensible, transiently relieving
the hypoxic constraint on the evolving lung. Over time, the increased distension of the alveoli
stimulates PTHrP secretion from the ATIIs, promoting alveolarization [27], providing a long-term
solution for adaptation to air breathing [68]. In tandem, catecholamines stimulate fatty acid secretion
from peripheral fat stores, increasing metabolism and body heat. The phospholipid composition
of surfactant in the alveoli of land vertebrates has evolved through progressive increases in the
percentage of dipalmitoylphosphatidylcholine (DPPC), which is 300% more bioactive at 37 ˝C than it
is at 25 ˝C due to its increased phase transition temperature [66], offering a mechanistic explanation
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for the positive selection for DPPC [69]. In support of the causal effect of the ambient atmospheric
temperature on lung surfactant phospholipid composition, Lau and Keogh [70] had shown such an
interrelationship experimentally in MAP turtles. Moreover, hibernation, in association with decreased
catecholamine production, demonstrates the opposite effect on the phosphatidylcholine content of
lung surfactant [71], lending credence to the environmental effect on lung surfactant composition and
surface tension reducing activity.
And since all of these properties are the net result of changes in cell-cell signaling mechanisms for
structure and function, they can be characterized as heterochronies.
7. Chronic Lung Disease as “Reverse” Heterochrony
Many chronic diseases such as emphysema and Bronchopulmonary Dysplasia are characterized
by structural simplification [72], atavistically reverting back to an earlier stage in their ontogeny
and phylogeny. In the lung, this relationship has been well delineated by the recognition of the
transdifferentiation of mesodermal fibroblasts from an adipocyte-like lipofibroblast to a myofibroblast,
reversing their direction both developmentally [73] and phylogenetically [62]. The cause of this loss of
differentiation is due to the breakdown in communication between the epithelial and mesenchymal
components of the alveolar wall that fostered the growth and differentiation of the alveoli during
development [7].
Similarly, modification of these cell-cell communications was responsible for the evolution of the
lung from the swim bladder [10] phylogenetically, and ultimately in evolutionary adaptation to air
breathing [12]. Thus, the heterochronic principle can be seen during the course of the reorientation of
the cell-cell signaling mechanisms in the tissues that evolved to adapt to a novel environment [9,10]. As
evidence of the causal nature of this mechanism, Peroxisome Proliferator Activated Receptor gamma
(PPARγ) agonists [74] can prevent this loss of differentiated structure and function because it acts on
the pathway that originally evolved to protect the lung against oxidant injury [41], referring all the way
back in vertebrate phylogeny to a more general adaptation to oxidant injury by mesodermal cells [75].
PPARγ regulates peroxisome formation [76], and as such refers to the stage in eukaryote evolution
when rising levels of oxygen caused Endoplasmic Reticulum Stress in unicellular organisms, resulting
in calcium leaking into the cytoplasm, threatening to congeal nucleotides, proteins and lipids alike [77].
The evolutionary epistatic balancing mechanism was the Peroxisome [39], which utilizes lipids to
buffer calcium dyshomeostasis. Therefore, the antecedents of the heterochronic redistribution of
genetic expression can be seen in this pathobiologic model of loss and gain of homeostasis as the
essence of evolution.
8. Goodpasture’s Syndrome as Waterproofing
Goodpasture’s Syndrome exhibits a similar evolutionary etiology. The disease state is due to
the formation of autoantibodies against an isoform of Type IV collagen, namely Alpha 3(IV)NC1.
It first appears phylogenetically in fish, and is omnipresent in amphibians, reptiles, mammals and
birds. Evolutionarily, it is more hydrophobic than other Type IV collagen isoforms, preventing water
loss across lung and kidney epithelial barriers in terrestrial vertebrates. Its appearance in land animals
was probably due to this adaptive property.
Bearing in mind that the extracellular matrix is generated by cell-cell interactions, this isoform of
Type IV collagen would have been the result of a heterochronic process.
9. Conclusions
The perspective expressed in this paper is that heterochrony is not a random mutational event,
but instead is like Jacob’s “tinkering” mechanism [78], reallocating biologic properties for novel uses
by “rewiring” cell-cell signaling mechanisms as the source of novel phenotypic change. Mutations can
occur within a specific biologic context, resulting in change consistent with the prevailing physical
constraint when “deciphered” by the biologic cell-cell signaling. This has been true right from the
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inception of life itself, the micelle providing a protected environment for the evolution of catalysis,
negentropy, chemiosmosis and homeostasis in order to cope with the vicissitudes of perpetual
environmental change [79]. The key to understanding this process is in focusing on the communication
between the organism and its environment, internalizing and compartmentalizing toxic substances
(oxygen, ions, heavy metals) that would otherwise have destroyed it, forming physiologic systems
in the process [8]. The subsequent formation of multicellular organisms was predicated on cell-cell
communication for further adaptation, but always returning to the unicellular state, perhaps because
it is the unicellular state that is the primary level of selection [10].
By seeing the process of evolution as communication, novel insights are gained that would
otherwise remain tautologies and dogma [80]. Kuhn [14] defined a paradigm shift as a change
in the language. The shift from heterochrony as a descriptive change in timing to alterations in
developmental-homeostatic mechanisms changes the language. This is analogous to the paradigm
shift in our understanding of gravity from Newton’s Law of Gravity that described the process to
Einstein’s explanation of gravity as the distortion of space-time.
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